A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head

被引：0
|
作者：
Yutaka Kuroda
Ryuta Asada
Kazutaka So
Atsushi Yonezawa
Manabu Nankaku
Kumi Mukai
Toshiko Ito-Ihara
Harue Tada
Michio Yamamoto
Toshinori Murayama
Satoshi Morita
Yasuhiko Tabata
Masayuki Yokode
Akira Shimizu
Shuichi Matsuda
Haruhiko Akiyama
机构：
[1] Kyoto University,Department of Orthopaedic Surgery, Graduate School of Medicine
[2] Gifu University Hospital,Clinical Research Center
[3] Kyoto University Hospital,Department of Clinical Pharmacology and Therapeutics
[4] Kyoto University Hospital,Rehabilitation Unit
[5] Kyoto University Hospital,Department of Clinical Innovative Medicine, Institute for Advancement of Clinical and Translational Research (iACT)
[6] Kyoto University Hospital,Department of Data Science, Institute for Advancement of Clinical and Translational Research (iACT)
[7] Kyoto University Hospital,Department of Experimental Therapeutics, Institute for Advancement of Clinical and Translational Research (iACT)
[8] Kyoto University,Department of Biomaterials, Field of Tissue Engineering, Institute for Frontier Medical Sciences
[9] Gifu University,Department of Orthopaedic Surgery
来源：
International Orthopaedics | 2016年 / 40卷
关键词：
Clinical trial; Femoral head; FGF; Growth factor; Osteonecrosis; Regenerative therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1747 / 1754
页数：7
相关论文
共 50 条
  • [1] A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head
    Kuroda, Yutaka
    Asada, Ryuta
    So, Kazutaka
    Yonezawa, Atsushi
    Nankaku, Manabu
    Mukai, Kumi
    Ito-Ihara, Toshiko
    Tada, Harue
    Yamamoto, Michio
    Murayama, Toshinori
    Morita, Satoshi
    Tabata, Yasuhiko
    Yokode, Masayuki
    Shimizu, Akira
    Matsuda, Shuichi
    Akiyama, Haruhiko
    INTERNATIONAL ORTHOPAEDICS, 2016, 40 (08) : 1747 - 1754
  • [2] Femoral head collapse rate among Japanese patients with pre-collapse osteonecrosis of the femoral head
    Asada, Ryuta
    Abe, Hiroyasu
    Hamada, Hidetoshi
    Fujimoto, Yusuke
    Choe, Hyonmin
    Takahashi, Daisuke
    Ueda, Shusuke
    Kuroda, Yutaka
    Miyagawa, Takaki
    Yamada, Kazuki
    Tanaka, Takeyuki
    Ito, Juji
    Morita, Satoshi
    Takagi, Michiaki
    Tetsunaga, Tomonori
    Kaneuji, Ayumi
    Inaba, Yutaka
    Tanaka, Sakae
    Matsuda, Shuichi
    Sugano, Nobuhiko
    Akiyama, Haruhiko
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (06)
  • [3] Prognosis after autologous peripheral blood stem cell transplantation for osteonecrosis of the femoral head in the pre-collapse stage: a retrospective cohort study
    Jiafei Pan
    Quanwei Ding
    Shuaijie Lv
    Bingjiang Xia
    Hongting Jin
    Di Chen
    Luwei Xiao
    Peijian Tong
    Stem Cell Research & Therapy, 11
  • [4] Prognosis after autologous peripheral blood stem cell transplantation for osteonecrosis of the femoral head in the pre-collapse stage: a retrospective cohort study
    Pan, Jiafei
    Ding, Quanwei
    Lv, Shuaijie
    Xia, Bingjiang
    Jin, Hongting
    Chen, Di
    Xiao, Luwei
    Tong, Peijian
    STEM CELL RESEARCH & THERAPY, 2020, 11 (01)
  • [5] The safety and efficacy of recombinant fibroblast growth factor 2 in human asthmatics: A pilot study
    Kim, Youn Seup
    Jang, Yong Ho
    Jeon, Ji Hyun
    Seo, Ji Hee
    Kang, Soo-Hyung
    Jee, Young-Koo
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2014, 2 (03): : 200 - 207
  • [6] Prognostic factors affecting periodontal regenerative therapy using recombinant human fibroblast growth factor-2: A 3-year cohort study
    Mikami, Risako
    Sudo, Takeaki
    Fukuba, Shunsuke
    Takeda, Kohei
    Matsuura, Takanori
    Kariya, Tomoaki
    Takeuchi, Shunsuke
    Ochiai, Akane
    Kawamoto, Sakurako
    Toyoshima, Keita
    Mizutani, Koji
    Arakawa, Shinichi
    Aoki, Akira
    Iwata, Takanori
    REGENERATIVE THERAPY, 2022, 21 : 271 - 276
  • [7] Periodontal regenerative therapy using recombinant human fibroblast growth factor (rhFGF)-2 in combination with carbonate apatite granules or rhFGF-2 alone: 12-month randomized controlled trial
    Imamura, Kentaro
    Yoshida, Wataru
    Seshima, Fumi
    Aoki, Hideto
    Yamashita, Keiko
    Kitamura, Yurie
    Murakami, Tasuku
    Ambiru, Mayuri
    Bizenjima, Takahiro
    Katayama, Akihiko
    Tomita, Sachiyo
    Saito, Atsushi
    CLINICAL ORAL INVESTIGATIONS, 2024, 28 (11)
  • [8] Recombinant human growth hormone therapy in malnourished dialysis patients:: A randomized controlled study
    Iglesias, P
    Díez, JJ
    Fernández-Reyes, MJ
    Aguilera, A
    Burgués, S
    Martínez-Ara, J
    Miguel, JL
    Gómez-Pan, A
    Selgas, R
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (03) : 454 - 463
  • [9] The safety and efficacy of recombinant fibroblast growth factor 2 in human asthmatics: A pilot study (vol 2, pg 200, 2014)
    Kim, Youn Seup
    Jang, Yong Ho
    Jeon, Ji Hyun
    Seo, Ji Hee
    Kang, Soo-Hyung
    Jee, Young-Koo
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2014, 2 (04): : 314 - 314
  • [10] THE SAFETY AND EFFICACY OF INHALED RECOMBINANT FIBROBLAST GROWTH FACTOR-2 IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A PILOT STUDY
    Hong, Goohyeon
    Jee, Young Koo
    Kim, Young Min
    Kang, Soo-Hyung
    Kim, Yoon-Keun
    RESPIROLOGY, 2015, 20 : 35 - 35
12345